GlassScriptPhysician profile
Jeffrey Todd Gardner
NPI 1063588200
$8,280.28
in general payments reported to CMS, 2019-2025
55 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,261 · 2020: $899 · 2021: $1,193 · 2022: $1,353 · 2023: $1,284 · 2024: $1,060 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,574.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $971.11 | 2019-2025 | |
| Abbvie INC. | $781.29 | 2019-2025 | |
| Novo Nordisk INC | $720.64 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $626.78 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $496.32 | 2019-2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $449.34 | 2019-2025 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $371.55 | 2021-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.66 | 2019-2025 | Jardiance, Ofev |
| Janssen Pharmaceuticals, INC | $321.10 | 2019-2022 | |
| Abbott Laboratories | $276.65 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $264.62 | 2019-2025 | Evenity, Prolia, Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $186.98 | 2022 | |
| Philips North America LLC | $158.09 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Biohaven Pharmaceuticals, INC. | $155.61 | 2021 | |
| Merck Sharp & Dohme LLC | $149.93 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.